Recalls / Generics / Pancrelipase
Pancrelipase
2 FDA drug recalls involving generic “Pancrelipase”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDC 0032-30 | Cardinal Health Inc. |
| 2014-09-15 | Class II | CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed | AbbVie Inc |